PositiveID Corp. (OTCQB:PSID) is preparing the launch of its latest innovation in bio-detection, and it could not come at a better time. In the midst of several epidemic outbreaks, PositiveID (“PSID”) is introducing Firefly Dx, a hand-held polymerase chain reaction (PCR) pathogen detection system capable of processing biological samples (e.g., blood, urine, mouth/nose swabs) on-site, alerting users within minutes of the presence of contagions. The Firefly Dx technology could prove vital for agencies entrusted with addressing public health needs on national and global levels. Continue Reading